Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3.
Published July 20, 2016 · Recall initiated: December 21, 2015
Summary
FDA records drug Class II recall D-1440-2016, published July 20, 2016 and initiated December 21, 2015. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 12285 boxes; Lot: Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.
What to do
Voluntary: Firm initiated · Letter
Get an email if DAYTRANA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DAYTRANA
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Distributor
- Nationwide
- Lot
- Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADaytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged inJuly 20, 2016
- FDAOxycodone HCl, Oral Solution USP, 5 mg/5 mL, 15 mL bottles, Rx only, Boehringer Ingelheim Roxane, Inc.,July 20, 2016
Questions about this recall
Was Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3. recalled?
Yes. FDA published recall D-1440-2016 on July 20, 2016. Reported hazard: Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DAYTRANA.